Feb 25, 2026
124:117
For every 117 shares held, investors received 124. The price per share adjusted from $1.88 to $1.78.
The split itself did not change the total investment value.
Oncopeptides AB (IOB:0RN4) operates in the Pharmaceuticals: major industry.
Oncopeptides AB company overviewOncopeptides AB's most recent stock split was on February 25, 2026. It was a 124-for-117 forward split, so shareholders received 124 shares for every 117 they held.
Oncopeptides AB (IOB:0RN4) has split its stock 3 times: a 87-for-62 split on April 16, 2024, a 645-for-608 split on August 27, 2025, and a 124-for-117 split on February 25, 2026.
Oncopeptides AB has split its stock 3 times. This history records 3 forward splits between April 16, 2024 and February 25, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Oncopeptides AB's 124-for-117 split on February 25, 2026, every 117 shares became 124 shares.
Oncopeptides AB has not announced a new split in our records. Its most recent split was on February 25, 2026, less than a year ago. Companies announce splits in advance, and any new IOB:0RN4 split will appear on this page.
Already premium?